BioSpace News Archive

Feb. 26, 2020 13:00 UTC SAN FRANCISCO--( BUSINESS WIRE )-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, will participate in a SynBio panel at the Cowen 40th Annual Health Care Conference on Tuesday, March 3 at 2:35 p.m. Eastern Time in Bos

Feb. 26, 2020 13:00 UTC Personalis, Inc. to Present at Immuno-Oncology 360˚ Conference MENLO PARK, Calif.--( BUSINESS WIRE )-- Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that the company will present at Immuno-Oncology 360˚ conference in New York, February 26-28. The presentation , titled “Comprehensive Immunogenomics to Enable Composite Biomarkers for Immunotherapy Response,” will describe the Personalis universal cancer imm

Feb. 26, 2020 13:05 UTC SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration with SOPHiA GENETICS, leader in Data-Driven Medicine to bring access to the universal SOPHiA Platform for advanced genomic analysis to Twist’s customers, providing the analysis and interpretation of sequencing inform

WARSAW, Ind., Feb. 26, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce that it was recently named one of the Best Places to Work in Indiana by the Indiana Chamber of Commerce and Best Companies Group. OrthoPediatrics’ recognition and inclusion in the fifteenth annual program is the fourth time the Company has been honored with this award. OrthoPediatrics’ President and Chief

Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that it has completed the acquisition of InstruNor AS, the privately held provider of the only fully integrated sample preparation system for flow and mass cytometry.

Leiters, a trusted FDA-registered 503B provider of high-quality compounded sterile preparations, announced its continued commitment to provide the highest quality compounded sterile preparations and pharmacy services to the healthcare market.

New initiative offers customers a way to attack cancer from every angle

Dialectic Therapeutics, Inc., a Texas-based biotechnology company focused on creating innovative new technologies to end cancer, today announced it has received a $3 million Seed Award for Product Development Research from the Cancer Prevention & Research Institute of Texas (CPRIT)

VerdePharmHealth, a cannabis group purchasing organization (VerdePharm GPO) coupled with a clinical education & healthcare technology solutions business (VerdePharm Solutions), today announces the appointment of Robert Rosen, Dr. Ralph Boccia, and Kirill Basin to the VerdePharmHealth Board of Directors.

Agreement Reflects Early Success of Axxess Implementations With Several Franchisees of Industry’s Largest and First Home Care Provider